Acasti Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.9%.

Top 23 shareholders own 59.65% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15.9%	Vimal Kavuru	1,614,399	€4.9m	35.9%	no data
9.46%	ADAR1 Capital Management, LLC	959,571	€2.9m	341%	0.56%
9.19%	SS Pharma LLC	931,743	€2.9m	0%	no data
7.71%	Iyer Sambamurty	781,592	€2.4m	0%	no data
6.32%	Aigh Capital Management, LLC	641,083	€2.0m	28.9%	0.96%
4.88%	Bank of America Corporation, Asset Management Arm	494,698	€1.5m	0%	no data
3.65%	S. Kottayil	370,354	€1.1m	0%	no data
1.23%	Kottayil Grace Pharma LLC	124,344	€381.1k	0%	no data
0.37%	Edward Neugeboren	37,895	€116.2k	0%	no data
0.37%	Susquehanna International Group, LLP, Asset Management Arm	37,793	€115.8k	3.12%	no data
0.21%	Prashant Kohli	21,357	€65.5k	0%	no data
0.11%	Amresh Kumar	11,118	€34.1k	-0.01%	no data
0.076%	UBS Asset Management AG	7,735	€23.7k	297%	no data
0.059%	Royal Bank of Canada, Banking & Securities Investments	6,000	€18.4k	-50%	no data
0.03%	Geode Capital Management, LLC	3,069	€9.4k	-1.98%	no data
0.029%	National Bank Investments Inc.	2,901	€8.9k	0%	no data
0.019%	Morgan Stanley, Investment Banking and Brokerage Investments	1,882	€5.8k	0%	no data
0.0058%	RBC Dominion Securities Inc., Asset Management Arm	584	€1.8k	0%	no data
0.0031%	Tidal Investments LLC	309	€948.0	-79.4%	no data
0.001%	Activest Wealth Management, LLC	104	€320.1	0%	no data
0.00028%	Fédération des Caisses Desjardins du Québec, Asset Management Arm	28	€87.0	0%	no data
0.00006%	IFP Advisors, LLC	6	€18.6	0%	no data
0.00002%	JPMorgan Chase & Co, Private Banking and Investment Banking Investments	2	€6.2	0%	no data